Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phage display affords peptides that modulate beta-amyloid aggregation.

Brendan P Orner1, Lin Liu, Regina M Murphy

  • 1Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

Journal of the American Chemical Society
|September 7, 2006
PubMed
Summary

Researchers used phage display to find peptides targeting beta-amyloid (Abeta) aggregates. Peptides binding to aggregated Abeta accelerated its aggregation, offering new ways to study protein aggregation diseases like Alzheimer's Disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Probes to Reveal the Assembly and Dynamics of Wall Teichoic Acids.

Journal of the American Chemical Society·2026
Same author

Principles of <i>in situ</i> protein sequencing: expansion microscopy-adapted Edman degradation and amino acid recognition.

bioRxiv : the preprint server for biology·2026
Same author

Intelectin-2 is a broad-spectrum antimicrobial lectin.

Nature communications·2026
Same author

The phenotypic landscape of the mycobacterial cell.

bioRxiv : the preprint server for biology·2025
Same author

Metabolic rewiring of isoniazid sensitivity in <i>Mycobacterium tuberculosis</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Intelectin-2 is a broad-spectrum antimicrobial lectin.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Protein aggregation diseases, such as Alzheimer's Disease (AD), are a growing concern with aging populations.
  • The specific toxic species of beta-amyloid (Abeta) protein aggregation in AD remains unclear.
  • Identifying agents that modulate Abeta aggregation is crucial for understanding AD pathogenesis.

Purpose of the Study:

  • To identify ligands that bind to specific forms of Abeta.
  • To investigate the effects of these ligands on Abeta aggregation dynamics and morphology.
  • To explore the potential of phage display in discovering modulators of protein aggregation.

Main Methods:

  • Phage display libraries were screened against monomeric and highly aggregated Abeta.

Related Experiment Videos

  • Selected peptides were tested for their ability to perturb Abeta aggregation.
  • Peptide affinity for the N-terminal region of Abeta was assessed.

    • Main Results:

    • Peptides selected against aggregated Abeta significantly increased the rate and altered the morphology of Abeta aggregation.
    • Peptides selected against monomeric Abeta did not affect aggregation.
    • The pro-aggregation effect correlated with peptide affinity for the Abeta N-terminus.

    Conclusions:

    • Ligands targeting the Abeta N-terminus can modulate Abeta aggregation.
    • Phage display is a viable method for identifying state-specific protein ligands.
    • These findings suggest potential therapeutic strategies for protein aggregation diseases by targeting specific Abeta forms.